MSH6 and colorectal carcinoma: In this patient cohort the lifetime risk for CRC at age 70 years was ~61% independent of gender, which is somewhat different from the lifetime risk of MSH6 mutation carriers presented in a previous study were there was a clear difference between males and females at age 70 years [32].